Agios Pharmaceuticals CEO Jacqualyn Fouse's 2021 pay slips 14% to $6.5M
Agios Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Agios Pharmaceuticals reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, seven executives at Agios Pharmaceuticals received on average a compensation package of $2.8M, a 19% decrease compared to previous year.
Average pay of disclosed executives at Agios Pharmaceuticals
Jacqualyn A. Fouse, Chief Executive Officer, received $6.5M in total, which decreased by 14% compared to 2020. 80% of Fouse's compensation, or $5.2M, was in option awards. Fouse also received $543K in non-equity incentive plan, $760K in salary, as well as $14K in other compensation.
For fiscal year 2021, the median employee pay was $315,091 at Agios Pharmaceuticals. Therefore, the ratio of Jacqualyn A. Fouse's pay to the median employee pay was 21 to one.
Jonathan Biller, Chief Financial Officer, received a compensation package of $2.8M, which increased by 268% compared to previous year. 50% of the compensation package, or $1.4M, was in option awards.
Bruce Car, Chief Scientific Officer, earned $2.8M in 2021, a 13% decrease compared to previous year.
Christopher Bowden, Chief Medical Officer, received $2.8M in 2021, which decreases by 4% compared to 2020.
Darrin Miles, Former Chief Commercial Officer, earned $2.5M in 2021.
Sarah Gheuens, Chief Medical Officer, received $1.2M in 2021.
Richa Poddar, Chief Commercial Officer, earned $1.1M in 2021.
Related executives
Jacqualyn Fouse
Agios Pharmaceuticals
Chief Executive Officer
Jonathan Biller
Agios Pharmaceuticals
Chief Financial Officer
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
Bruce Car
Agios Pharmaceuticals
Chief Scientific Officer
Sarah Gheuens
Agios Pharmaceuticals
Chief Medical Officer
Darrin Miles
Agios Pharmaceuticals
Former Chief Commercial Officer
Richa Poddar
Agios Pharmaceuticals
Chief Commercial Officer
You may also like
Source: SEC filing on April 28, 2022.